Company intelligence / Profile preview

Natural MedTech

Melbourne, Victoria, Australiaau.linkedin.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Natural MedTech is developing biosynthetic and proprietary formulations of psychedelic compounds such as psilocybin and DMT. The company partners with leading Australian universities to develop sustainable manufacturing processes. Their products are being used in formal clinical research targeting major depressive disorder and other mental health conditions. A referenced Phase 2 study using psilocybin showed a remission rate of 79% in patients with major depressive disorder after two doses. The company is active in both preclinical development and supplying GMP-grade materials for ongoing clinical studies.

Therapeutic areas
PsychiatryNeurology
Modalities
Small molecule (tryptamines, psychedelics such as psilocybin, psilocin, N,N-DMT, 5-MeO-DMT)Proprietary formulations (likely small molecules/psychedelic derivatives)
Industry
Biotech
02

Drug pipeline

1 asset

psilocybin

Commercial
Indications
Depression, PTSD, Anxiety, Alcohol addiction, Anorexia nervosa, Obsessive-compulsive disorder, Tourette syndrome
03

Partnerships

University of Western Australia/Heng Chooi lab – bioproduction R&D partnershipUniversity of South Australia/Sanjay Garg group – formulation/manufacturing partnershipCSIRO – grant funding/collaboration on psychoactive plant/fungi research

Beyond the preview

Go deeper on Natural MedTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural MedTech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call